Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection
- PMID: 1624567
- PMCID: PMC265314
- DOI: 10.1128/jcm.30.6.1479-1484.1992
Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection
Abstract
The titer and avidity of respiratory syncytial virus-specific antibodies were measured in 196 serum specimens from 93 children with an acute, laboratory-confirmed respiratory syncytial virus infection. An enzyme immunoassay method based on the ability of urea to dissociate the bound antibodies with low avidity from the antigen was used. Three patterns of immune responses were observed. Children less than 6 months of age usually had low titers of antibodies with high avidity in their acute-phase serum samples. These antibodies were concluded to be of maternal origin, since their reaction pattern was similar to that of healthy adults. During the next few weeks, a slight increase in titers with a concurrent decrease in antibody avidity was observed. All children 6 to 24 months of age had low-avidity antibodies in their acute-phase serum samples, which matured to high avidity during the follow-up. On the contrary, about half of the children greater than 24 months of age had high-avidity antibodies already in the acute-phase serum samples. We conclude that the former children were experiencing primary infections with respiratory syncytial virus and the latter were experiencing reinfections. All adults with remote immunity had antibodies with high avidity.
Similar articles
-
Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.J Med Virol. 2011 Oct;83(10):1826-33. doi: 10.1002/jmv.22134. J Med Virol. 2011. PMID: 21837801
-
Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay.J Med Virol. 1984;14(1):67-72. doi: 10.1002/jmv.1890140110. J Med Virol. 1984. PMID: 6747613
-
Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.J Clin Virol. 1998 Aug 20;11(2):137-47. doi: 10.1016/s1386-6532(98)00045-2. J Clin Virol. 1998. PMID: 9785215
-
Immunity to human and bovine respiratory syncytial virus.Arch Virol. 1990;112(1-2):1-25. doi: 10.1007/BF01348982. Arch Virol. 1990. PMID: 2196033 Review.
-
[Effect of the humoral immune response on the pathogenesis of respiratory syncytial virus (RSV) infection].Immun Infekt. 1993 Jun;21(3):75-7. Immun Infekt. 1993. PMID: 8335338 Review. German.
Cited by
-
Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.J Clin Microbiol. 2004 Apr;42(4):1782-4. doi: 10.1128/JCM.42.4.1782-1784.2004. J Clin Microbiol. 2004. PMID: 15071049 Free PMC article.
-
Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.EBioMedicine. 2017 Feb;16:124-135. doi: 10.1016/j.ebiom.2017.01.014. Epub 2017 Jan 16. EBioMedicine. 2017. PMID: 28111238 Free PMC article.
-
Advances in the diagnosis of respiratory virus infections.Clin Diagn Virol. 1996 May;5(2-3):91-100. doi: 10.1016/0928-0197(96)00210-3. Clin Diagn Virol. 1996. PMID: 15566867 Free PMC article.
-
Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.J Virol. 1997 Jul;71(7):5069-79. doi: 10.1128/JVI.71.7.5069-5079.1997. J Virol. 1997. PMID: 9188572 Free PMC article.
-
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19.Int J Mol Sci. 2025 Jul 4;26(13):6462. doi: 10.3390/ijms26136462. Int J Mol Sci. 2025. PMID: 40650237 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources